Saquinavir as Fortovase: why does it matter?
Trapnell
C B
CB
US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Biologics Evaluation and Research, Bethesa, MD.
D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D019540:Area Under Curve; D001682:Biological Availability; D004304:Dosage Forms; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D019258:Saquinavir / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use
D019380:Anti-HIV Agents; D004304:Dosage Forms; D017320:HIV Protease Inhibitors; D019258:Saquinavir